Research Lab of David Auerbach, PhD
The Auerbach Lab strives for a scientifically productive environment, through providing an inclusive and collegial environment for people to work together to advance our understanding of neuro-cardiac electrical disturbances. The group works together to mentor younger scientists, teach others new scientific approaches, and promote scientifically sound and reproducible results.
Bedside to Bench to Bedside Research Approach
- October 2023: David Auerbach has been awarded over $1 million from the National Institute of Neurological Disorders and Stroke over the next three years: Groundbreaking Research Aims to Prevent SUDEP: Investigating the Link Between Epilepsy and Heart Rhythm Disorders
- August 2023: Justin Ryan, Kyle Wagner, and David Auerbach author a paper in Seizure: Heart rate and autonomic biomarkers distinguish convulsive epileptic vs. functional or dissociative seizures.
- August 2023: NIH R61/R33 IGINTE grant: Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type-2, (1 R61 NS133273-01: PI: David S. Auerbach, PhD; Co-I: Justin M. Ryan, PhD)
- August 2023: Veronica Singh passed the qualifying exam and is now a PhD candidate.
- May 2023: Veronica Singh, Justin Ryan, and David Auerbach author a commentary paper in Epilepsia: It is Premature for a Unified Hypothesis of SUDEP: A Great Amount of Research is Still Needed to Understand the Multi-System Cascade
- April 2023: University of Rochester Clinical and Translational Science Institute (CTSI) UNYTE grant for translational science: Wearable Multi-System Recordings for Improved Disease Diagnostics (co-PI: David S. Auerbach & Inna Hughes [URMC]; Co-I: Justin M. Ryan)